GLP-1 Multi-District Litigation | Updates And What You Need To Know Jun 28, 2025 4 min read The wave of lawsuits involving GLP-1 receptor agonistssuch as Ozempic, Wegovy, Trulicity, and Mounjarohas evolved into one of the most closely watched mass torts in the country
GHK-Cu Research Applications Researchers across the globe study GHK-Cu for its potential applications in cellular biology, tissue engineering, regenerative medicine, and molecular signaling pathways
Novel perspectives on the link between obesity and cancer risk: from mechanisms to clinical implications
Trends Pharmacol Sci 2006
$129.99 KLOW 80MG Klow Peptide Blend is formulated for controlled laboratory and analytical applications involving peptide signaling activity, cellular response modeling, and molecular interaction studies